IRIS
CILIBERTO, GENNARO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.095
AS - Asia 5.846
EU - Europa 2.138
SA - Sud America 1.865
AF - Africa 119
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 19
Totale 19.103
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.775
SG - Singapore 2.562
BR - Brasile 1.502
CN - Cina 1.345
IT - Italia 841
VN - Vietnam 795
IN - India 681
SE - Svezia 418
GB - Regno Unito 380
CA - Canada 219
DE - Germania 166
AR - Argentina 141
HK - Hong Kong 87
BD - Bangladesh 77
EC - Ecuador 69
MX - Messico 67
ID - Indonesia 65
ZA - Sudafrica 47
FI - Finlandia 46
JP - Giappone 44
RU - Federazione Russa 42
IQ - Iraq 39
CO - Colombia 37
CL - Cile 35
NL - Olanda 34
UA - Ucraina 34
PL - Polonia 33
PY - Paraguay 31
ES - Italia 28
VE - Venezuela 22
MA - Marocco 21
RO - Romania 19
SA - Arabia Saudita 19
TR - Turchia 17
PK - Pakistan 15
UZ - Uzbekistan 15
AU - Australia 14
IR - Iran 14
AE - Emirati Arabi Uniti 13
CZ - Repubblica Ceca 13
PE - Perù 13
EG - Egitto 12
EU - Europa 12
KE - Kenya 12
FR - Francia 11
UY - Uruguay 10
IE - Irlanda 9
LT - Lituania 9
AT - Austria 8
AZ - Azerbaigian 7
GR - Grecia 7
JM - Giamaica 7
JO - Giordania 7
TN - Tunisia 7
AL - Albania 6
IL - Israele 6
NZ - Nuova Zelanda 6
SN - Senegal 6
TT - Trinidad e Tobago 6
BO - Bolivia 5
DZ - Algeria 5
HN - Honduras 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BB - Barbados 4
CH - Svizzera 4
EE - Estonia 4
KZ - Kazakistan 4
BG - Bulgaria 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
KR - Corea 3
LB - Libano 3
MY - Malesia 3
NO - Norvegia 3
NP - Nepal 3
XK - ???statistics.table.value.countryCode.XK??? 3
BE - Belgio 2
DK - Danimarca 2
KG - Kirghizistan 2
MD - Moldavia 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
GM - Gambi 1
Totale 19.087
Salva come PNG Salva come JPEG
Città #
Chandler 1.195
Dallas 1.044
San Jose 705
Singapore 666
Santa Clara 589
Hefei 580
Bengaluru 578
Milan 516
Princeton 499
Lawrence 495
Ashburn 494
Chicago 327
London 301
Wilmington 295
Ho Chi Minh City 291
Ottawa 165
Hanoi 162
Des Moines 153
Beijing 145
Boardman 136
São Paulo 128
Munich 123
Hong Kong 82
Los Angeles 70
Shanghai 62
New York 50
Guangzhou 46
Council Bluffs 45
Norwalk 42
Pune 42
Rome 42
Rio de Janeiro 39
Haiphong 36
Turku 36
Tokyo 35
Brooklyn 34
Catanzaro 34
The Dalles 34
Brasília 31
San Francisco 30
Da Nang 29
Porto Alegre 27
Belo Horizonte 26
Boston 26
Columbus 25
Warsaw 25
Campinas 24
Curitiba 23
Guayaquil 23
Redmond 23
Wuhan 23
Hải Dương 22
Quito 22
Redwood City 22
Johannesburg 21
Biên Hòa 20
Montreal 20
Naples 20
Ninh Bình 20
Atlanta 19
Mexico City 19
Asunción 18
Buenos Aires 18
Dhaka 18
Stockholm 18
Thái Bình 18
Salvador 17
Assago 16
Baghdad 16
Shenzhen 16
Falls Church 15
Jakarta 14
Manaus 14
Phoenix 14
Thái Nguyên 14
Washington 14
Bắc Ninh 13
Chennai 13
Guarulhos 13
Santo André 13
Tashkent 13
Can Tho 12
Charlotte 12
Seattle 12
Wuxi 12
Ann Arbor 11
Ha Long 11
Maceió 11
Rui'an 11
Amsterdam 10
Bauru 10
Helsinki 10
Jinan 10
Manchester 10
Nairobi 10
Sorocaba 10
Cape Town 9
Contagem 9
Petrópolis 9
Raleigh 9
Totale 11.359
Salva come PNG Salva come JPEG
Nome #
The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2 476
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study 79
ADENOVIRAL VECTORS ENCODING ERYTHROPOIETIN AND THEIR USE IN GENE THERAPY 78
59. Structural characterization of a biologically active human Lipocortin 1 expressed in Escherichia coli 75
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130 70
Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition. 69
A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro 68
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 68
A novel method for site-directed mutagenesis: its application to an eukaryotic tRNAPro gene promoter 67
A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and non-hepatic origin 67
T-CELL PEPTIDE EPITOPES FROM CARCINOEMBRYONIC ANTIGEN, IMMUNOGENIC ANALOGS, AND USES THEREOF 66
ADENOVIRAL VECTORS FOR MUTANTS OF HUMAN INTERLEUKIN 6 (HIL-6) WITH HIL-6 ANTAGONIST ACTIVITY, PHARMACEUTICAL COMPOSITIONS THEREWITH AND THEIR USES 66
A novel minigene scaffold for therapeutic cancer vaccines 65
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines 65
A PARADIGM SHIFT FOR ERYTHROPOIETIN: NO LONGER A SPECIALIZED GROWTH FACTOR, BUT RATHER THAN AN ALL-PURPOSE TISSUE-PROTECTIVE AGENT 65
A fast and sensitive colorimetric assay for IL-6 on hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP) 64
A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice 63
Monitoring of melanoma clinical progression by circulating NK and T cells immunoprofiling: a potential role for CCR7 in metastatic spread 63
A functionally orthogonal estrogen Receptor-based transcription switch Tightly controlled by a non-steroid synthetic ligand 63
A Multimeric Synthetic Combinatorial peptide library. A Multimeric Synthetic Combinatorial peptide library 62
A prokaryotic tRNA Tyr gene,inactive in Xenpous Laevis oocytes, is activated by recombination with an eukaryotic tRNA Pro gene 62
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP) 61
Interleukin 6 deficient mice are protected from bone loss caused by estrogen depletion 61
A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent 59
Analysis of T and Natural Killer cells immune response in Ipilimumab treated 59
RHESUS EPITHELIAL CELL ADHESION MOLECULE, NUCLEIC ACID ENCODING THE SAME, AND USES THEREOF 58
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells 58
Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs 57
Adenovirus-mediated gene transfer of a human IL-6 antagonist 57
A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses 56
Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer 55
ANTAGONISTS OF HUMAN INTERLEUKIN-6 THAT ARE TOTALLY INCAPABLE OF BINDING GP 130, AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOUNDS 54
CHIMERIC BIOMARKER FOR THE EARLY DIAGNOSIS AND IMMUNOTHERAPY OF CANCER 54
PREPARATION OF RECOMBINANT ADENOVIRUS CARRYING A REP GENE OF ADENO-ASSOCIATED VIRUS 54
Liver failure and defective hepatocyte regeneration in Interleukin-6 deficient mice 53
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope 53
Cancer stem cells and the slow cycling phenotype: How to cut the gordian knot driving resistance to therapy in melanoma 53
An improved helper-dependent adenoviral vector allows persistent gene expression after i.m. delivery and overcomes pre-existing immunity to adenovirus 52
Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system 52
MicroRNAs regulate resistance to target therapy in melanoma 52
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave? 52
HORMONE-DEPENDENT FORMS OF THE ADENO-ASSOCIATED VIRUS, REP PROTEINS, DNA SEQUENCES CODING FOR THEM, VECTORS CONTAINING THEM, AND REGULATORY METHODS OF THEIR INTRACELLULAR ACTIVITY 51
MUTANT INTERLEUKIN 6 WITH IMPROVED BIOLOGICAL ACTIVITY OVER WILD INTERLEUKIN 6 51
WT1 CpG islands methylation in human lung cancer: a pilot study 51
A federated learning system for precision oncology in Europe: DigiONE 50
Monovalent phage display of human Interleukin (hIL)-6: selection superbinder variants for a complex molecular repertoire in hIL-6 D-Helix 50
miR-579-3p controls melanoma progression and resistance to target therapy 50
Inhibition of Stearoyl-Coa desaturase 1 (SCD1) enzymatic activity reverts BRAFi and MEKi-induced selection of cancer stem cells in BRAF-mutated malignant melanoma 50
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance 49
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 49
IMMUNOTHERAPY AGAINST ERBB-3 RECEPTOR 49
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience 49
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience 49
PROGRESS AND PROSPECTS: TRANSCRIPTION REGULATORY SYSTEMS 48
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients 48
ANTI-TUMOUR PHARMACEUTICAL COMPOSITIONS CAPABLE OF REDUCING DRUG RESISTANCE IN TUMOUR CELLS 48
Liver specific expression of cloned human genes 48
CD8+ T CELL TOLERANCE CAN BE BROKEN BY AN ADENOVIRUS VACCINE WHILE CD4+ T CELL TOLERANCE IS BROKEN BY ADDITIONAL CO-ADMINISTRATION OF A TOLL-LIKE RECEPTOR LIGAND 47
Intratumor RNA interference of cell cycle genes slows down tumor progression 47
Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling 47
Phenotype characterization of human melanoma cells resistant to dabrafenib 47
Regulation of C-reactive protein, haptoglobin and hemopexin gene expression 47
In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist 47
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome 47
Involvement of the Arg179 in the active site of human IL-6 47
The emerging role of cancer cell plasticity and cell-cycle quiescence in immune escape 47
Leptin receptor-mediated regulation of cholinergic neurotransmitter phenotype in cells of central nervous system origin 46
A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomas 46
RHESUS HER2/NEU, NUCLEOTIDES ENCODING SAME, AND USES THEREOF 46
CARCINOEMBRYONIC ANTIGEN FUSIONS PROTEINS AND USES THEREOF 46
INTERLEUKIN-6 (IL-6) ANTAGONISTS 46
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas 46
RECOMBINANT VECTORS DERIVED FROM ADENO-ASSOCIATED VIRUS SUITABLE FOR GENE THERAPY 46
Telomerase Reverse Transcriptase Fusion Protein , Nucleotides Encoding it, and uses thereof 46
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study 45
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma 45
DNA sequence of a pseudogene for human C-reactive protein 45
Epigenetic Changes Induced by Green Tea Catechins are Associated with Prostate Cancer 45
Pyrvinium pamoate induces death of triple-negative breast cancer stem-like cells and reduces metastases through effects on lipid anabolism 45
Liver-Specific –Alpha 2 Interferon Gene Expression Results in Protection from Induced Hepatitis 44
Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway. 44
Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial 44
B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells 44
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 44
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives 44
Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth 43
Deducing the functional characteristics of the human selenoprotein SELK from the structural properties of its intrinsically disordered C-terminal domain 43
The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma 43
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016 43
MULTI-ANTIGEN CONSTRUCT AND USES THEREOF 43
Interleukin-6 an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells 43
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non–Small-Cell Lung Cancer 43
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions 42
Regulated and prolonged expression of mIFN(alpha) in immunocompetent mice mediated by a helper-dependent adenovirus vector. 42
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma 42
ORTHOGONAL GENE SWITCHES 42
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 42
The reciprocal interplay between miR-579-3p and MITF controls melanoma proliferation and resistance to target therapy 42
Electro gene-transfer results in a high level transduction of rat skeletal muscle and corrects anaemia of renal failure 42
Human IL-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells 42
Totale 5.638
Salva come PNG Salva come JPEG
Categoria #
all - tutte 227.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021157 0 0 0 0 0 0 45 23 41 26 4 18
2021/20221.332 20 5 9 316 114 27 60 287 119 153 211 11
2022/20233.544 1.002 62 32 348 446 333 1 259 605 201 212 43
2023/20241.420 349 215 129 79 63 380 49 22 16 24 43 51
2024/20254.729 788 408 184 150 173 601 76 197 702 255 303 892
2025/20267.888 446 1.433 1.553 2.313 992 304 847 0 0 0 0 0
Totale 19.426